WUHAN, China I, 2025 I Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address ...
NEW YORK, NY, USA and VIENNA, Austria I January 02, 2025 I The boards of directors (each a “Board”) of HOOKIPA Pharma Inc. (“HOOKIPA”) and Poolbeg Pharma plc ...
CAMBRIDGE, MA, USA I January 02, 2025 I Atavistik Bio, a biotechnology company committed to discovering the next generation of precision allosteric ...
SAN FRANCISCO, CA, USA and SUZHOU, China I January 1, 2025 I Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company ...
SHANGHAI, China I December 31, 2024 I CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for ...
Further secures Brii's rights in BRII-179 with full control of intellectual property, future manufacturing and supply ...
HAMILTON, Bermuda I December 31, 2024 I Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and ...
BASEL, Switzerland I 30, 2024 I Novartis today announced positive topline results from the Phase III STEER study. This pivotal study assessed the ...
SOMERSET, NJ, USA & SHANGHAI and SUZHOU, China I 30, 2024 I Duality Biologics ("DualityBio") announced that, BeiGene. Ltd. has exercised its ...
New indication based on results from a global Phase 3 trial demonstrating TEVIMBRA plus chemotherapy significantly improved overall survival for patients with ...
REDWOOD CITY, CA, USA I 30, 2024 I Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and ...
STOCKHOLM, Sweden & RADNOR, PA, USA I December 30, 2024 I Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback